Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

Also called NCT02555111

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 112 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02555111
  • EudraCT 2015-001190-40
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02555111. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2020-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
Acronym
RIPORT
Condition
Chronic Portal Vein Thrombosis
Intervention (Drug)
Xarelto
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct02555111
Content hash
4a92e8a73c6eeecd18a356902af94ef94c0e409d1eab506adbd5d04224f1d510